TABLE 1.
Patient | Strain | Isolation date (day/mo/yr) | Drug resistance shown by proportion method | Mutation shown by:
|
|
---|---|---|---|---|---|
LiPA | Sequencinga | ||||
1 | 10603 | 21/12/2004 | INH, RMP, SM | ΔS5 | S531W |
5585 | 12/05/2005 | INH, RMP, SM, EMB | ΔS5 | S531W | |
4522 | 12/07/2006 | INH, RMP, SM, EMB | ΔS5 | S531W | |
2 | 15 | 03/01/2006 | INH, RMP | R5b | S531L |
3267 | 28/04/2006 | INH, RMP | R5 | S531L | |
3 | 9796 | 25/11/2005 | INH, RMP, EMB, SM | ΔS4/ΔS5 | H526C/S531A |
1409 | 28/02/2006 | INH, RMP, EMB, SM | ΔS4/ΔS5 | H526C/S531A | |
4 | 2603 | 03/03/2006 | INH, RMP | R5 | S531L |
5 | 9742 | 23/11/2005 | INH, RMP, SM, CIP | ΔS4/ΔS5 | H526C/S531A |
6 | 4164 | 29/05/2006 | INH, RMP, EMB | ΔS5 | S531W |
Sequencing mutation descriptions are as follows: first, the amino acid residue in the wild-type sequence, then the codon position, and finally the amino acid residue in the mutated sequence. The numbering system is based on the Escherichia coli β-subunit of RNA polymerase (25).
R5, S531L.